TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia
东南亚中低收入国家结核病/耐多药结核病研究能力建设
基本信息
- 批准号:9207135
- 负责人:
- 金额:$ 21.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:AfricaAsiaBiometryCommunicable DiseasesData AnalysesData CollectionData ReportingDoctor of PhilosophyEducational CurriculumEnsureEpidemiologyFacultyFutureGoalsHome environmentHospitalsHuman ResourcesIndonesiaInstitutesLaboratoriesLeadMedical ResearchMicrobiologyMulti-Drug ResistanceMyanmarResearchResearch MethodologyResearch PersonnelScienceSoutheastern AsiaSumatraThailandTrainingTraining ProgramsTuberculosisUniversitiesWritingacetone hydrazonebasecareer developmentexperiencelow and middle-income countriesprogramsresponsible research conduct
项目摘要
DESCRIPTION (provided by applicant): This training program's goal is to strengthen TB research capacity, especially human resources of TB research at LMIC collaborating centers, namely the National Tuberculosis Program of Myanmar; Department of Medical Research Upper and Lower Myanmar; Bureau of Tuberculosis of Thailand (BTB); and University of North Sumatra (USU), Andalas University of West Sumatra (UNAND), and Syiah Kuala University of Aceh (SKU), Indonesia. The training program will focus on multidrug-resistant TB (MDR-TB), which is a major problem in the Southeast Asia region. This will eventually lead to better future control of TB and other global infectious diseases. The program objectives are to train researchers from collaborating centers (LMIC-Indonesia, Myanmar and Thailand) to achieve MSc/PhD in Epidemiology at Prince of Songkla University, with a special focus on MDR-TB research, and to provide short course training in TB Epidemiology/Biostatistics and TB laboratory science to various researchers of the collaborating centers. The long-term training to produce 6 PhD and 6 MSc graduates will be based at the Epidemiology Unit, Prince of Songkla University (EPI-PSU), experienced in producing over 130 epidemiological Doctoral and Master researchers to Asia and Africa. This is incorporated with supplementary short-term training at the Departments of Microbiology at Siriraj Hospital and Faculty of Science of Mahidol University (MICRO-MU), and at a center of excellence for TB research and TB field observation at Zonal TB Center 12 Yala (ZTC12). In addition, short-term training will be conducted at EPI-PSU to train 19 researchers and at MICRO-MU to train 14 researchers. All trainees will be initially selected by the target institutes from Myanmar, Indonesia and Thailand, and reviewed by a Training Advisory Group (TAG). The long-term training curriculum consists of one year coursework (shared by PhD and MSc programs) emphasizing Epidemiology/Biostatistics, Research Methodology, Responsible Conduct of Research, and data analysis. This is followed by data collection for research thesis related to MDR-TB (1 year for PhD and 6 months for MSc) at home institutes of the trainees. Finally, another year for the PhD and 6 months for the MSc trainees will be spent on data analysis and report writing at EPI-PSU. Apart from technical quality, arrangement has been made to ensure enough diversity of trainees, maximum retention and continuation of research career development after the training has been completed.
描述(由申请人提供):该培训计划的目标是加强结核病研究能力,特别是中低收入国家合作中心(即缅甸上下游结核病医学研究部)的结核病研究人力资源;泰国(BTB);北苏门答腊大学(USU)、西苏门答腊安达拉斯大学(UNAND)和印度尼西亚亚齐亚瓜拉大学(SKU)。培训计划将重点关注耐多药结核病(MDR-TB),这是东南亚地区的一个主要问题,这最终将导致未来更好地控制结核病和其他全球传染病。该计划的目标是培训来自东南亚地区的研究人员。合作中心(中低收入国家-印度尼西亚、缅甸和泰国)在宋卡王子大学获得流行病学理学硕士/博士学位,特别关注耐多药结核病研究,并提供结核病短期课程培训流行病学/生物统计学和结核病实验室科学领域的各个研究人员将在宋卡王子大学流行病学部门(EPI-PSU)进行长期培训,以培养 6 名博士和 6 名硕士毕业生。 130 名流行病学博士和硕士研究人员前往亚洲和非洲,这与 Siriraj 医院微生物学系和 Mahidol 科学学院的补充短期培训相结合。大学 (MICRO-MU),以及亚拉 12 区结核病中心 (ZTC12) 的结核病研究和结核病现场观察卓越中心。此外,还将在 EPI-PSU 和 19 名研究人员进行短期培训。 MICRO-MU将培训14名研究人员,所有学员将由来自缅甸、印度尼西亚和泰国的目标机构初步选拔,并由培训顾问小组(TAG)审核。长期培训课程为期一年。课程作业(由博士和理学硕士课程共享)强调流行病学/生物统计学、研究方法、负责任的研究行为和数据分析,随后是与耐多药结核病相关的研究论文的数据收集(博士为 1 年,理学硕士为 6 个月)。 )最后,博士生还需要一年的时间,硕士生还需要六个月的时间在 EPI-PSU 进行数据分析和报告撰写。已做出安排,以确保受训者有足够的多样性,最大限度地保留并在培训完成后继续研究职业发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angkana Chaiprasert其他文献
Angkana Chaiprasert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angkana Chaiprasert', 18)}}的其他基金
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段:促进多样性、公平和包容性 (DEI)
- 批准号:
10873650 - 财政年份:2023
- 资助金额:
$ 21.59万 - 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: End-of-Fiscal-Year Supplement
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段:财年末补充文件
- 批准号:
10877205 - 财政年份:2023
- 资助金额:
$ 21.59万 - 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
- 批准号:
10393653 - 财政年份:2015
- 资助金额:
$ 21.59万 - 项目类别:
TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia
东南亚中低收入国家结核病/耐多药结核病研究能力建设
- 批准号:
8890980 - 财政年份:2015
- 资助金额:
$ 21.59万 - 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
- 批准号:
10577817 - 财政年份:2015
- 资助金额:
$ 21.59万 - 项目类别:
TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II
东南亚中低收入国家结核病/耐多药结核病研究培训和能力强化第二阶段
- 批准号:
10238181 - 财政年份:2015
- 资助金额:
$ 21.59万 - 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
- 批准号:
8502235 - 财政年份:2010
- 资助金额:
$ 21.59万 - 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
- 批准号:
8298473 - 财政年份:2010
- 资助金额:
$ 21.59万 - 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
- 批准号:
7934826 - 财政年份:2010
- 资助金额:
$ 21.59万 - 项目类别:
MAS-PCR Rapid Screening Test for Multidrug-Resistant Tuberculosis (MDR-TB)
MAS-PCR 耐多药结核病 (MDR-TB) 快速筛查试验
- 批准号:
8111903 - 财政年份:2010
- 资助金额:
$ 21.59万 - 项目类别:
相似国自然基金
亚洲降水同位素轨道尺度变化特征、机制及其区域差异的数值模拟研究
- 批准号:42375051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
亚洲中部干旱区过去千年、现代及未来的温湿配置格局及其与全球干旱区的对比研究
- 批准号:42371158
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
晚中新世-早上新世全球变暖对亚洲干旱-季风过渡区干湿变化影响研究——以柴达木盆地为例
- 批准号:42301007
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
古亚洲南缘晚白垩世大洋缺氧事件(OAE 2)记录
- 批准号:42372123
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
亚洲夏季风降水的季节内可预报性及上层海洋作用研究
- 批准号:42376020
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Better Together: Leveraging primary care and social network resources to create a patient-centered approach to improve diabetes among immigrant communities
更好地在一起:利用初级保健和社交网络资源创建以患者为中心的方法来改善移民社区的糖尿病
- 批准号:
10366084 - 财政年份:2020
- 资助金额:
$ 21.59万 - 项目类别:
Better Together: Leveraging primary care and social network resources to create a patient-centered approach to improve diabetes among immigrant communities
更好地在一起:利用初级保健和社交网络资源创建以患者为中心的方法来改善移民社区的糖尿病
- 批准号:
10589073 - 财政年份:2020
- 资助金额:
$ 21.59万 - 项目类别:
Better Together: Leveraging primary care and social network resources to create a patient-centered approach to improve diabetes among immigrant communities
更好地在一起:利用初级保健和社交网络资源创建以患者为中心的方法来改善移民社区的糖尿病
- 批准号:
10198690 - 财政年份:2020
- 资助金额:
$ 21.59万 - 项目类别:
Malaria Management through an On-demand Diagnostic Approach using Novel Ionic Probes
使用新型离子探针通过按需诊断方法进行疟疾管理
- 批准号:
10399621 - 财政年份:2019
- 资助金额:
$ 21.59万 - 项目类别: